Who invested in Click Therapeutics?
Click Therapeutics's investors include SVB Capital, Sanofi, Boehringer Ingelheim, Accel and HSBC.

United States · Series D startup
3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 1 month ago
Follow Click Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$149Mraised across 3 rounds since 2025, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $50M sold, first sale Oct 2026
Reported by Revelation Partners and 1 other
From Click Therapeutics's own website: 1 founder, 8 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Click Therapeutics's investors include SVB Capital, Sanofi, Boehringer Ingelheim, Accel and HSBC.
Click Therapeutics has raised $149M across 3 rounds since 2025.
Click Therapeutics's most recent round, $50M, was in Oct 2026.
Click Therapeutics's largest round on record is $50M (Series D), in May 2026, led by Boehringer Ingelheim.
Click Therapeutics's first round on record, in Mar 2025, was backed by SVB Capital, HSBC and Sanofi.
Click Therapeutics's latest named round is a Series D, in May 2026.
Click Therapeutics is based in the United States.
Boehringer Ingelheim led the Series D in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.